Two-thirds of patients with moderate or severe plaque psoriasis had complete or nearly complete clearance at 4 months with an oral peptide targeting interleukin (IL)-23, a randomized study showed. The ...

Knowing which kind of psoriasis you have helps you and your doctor make a treatment plan. Most people have only one type at a time. Experts believe psoriasis is an autoimmune disease.

Late-stage data also showed that Johnson & Johnson’s icotrokinra was superior to Bristol Myers Squibb’s Sotyktu at clearing ...

Cardiac Risks With Newer Psoriasis Meds Match TNF Inhibitors A study of biologic-naive patients with psoriasis or PsA found that IL-17, IL-12/23, and IL-23 inhibitors have cardiovascular and ...

"New treatment option for psoriasis discovered." ScienceDaily. www.sciencedaily.com / releases / 2025 / 03 / 250303141858.htm (accessed March 18, 2025). Explore More ...